Clinical Trials on Hematopoietic Malignancy

Total 4940 results

Ohio State University Comprehensive Cancer Center

Completed

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Malignant Solid Neoplasm | Type 2 Diabetes Mellitus | Hematopoietic and Lymphoid System Neoplasm

United States
National Institute of Diabetes and Digestive and...

Not yet recruiting

Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplant

United States
Chinese PLA General Hospital

Active, not recruiting

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation

China
Federal University of Minas Gerais

Completed

Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation

Brazil
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers

Hematopoietic Cell Transplantation Recipient

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Non Randomized Comparative Study With Control (Allo-NK-CMV)

Allogeneic Hematopoietic Stem Cell Transplantation

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Allogeneic Hematopoietic Stem Cell Transplant Recipient

United States
Mayo Clinic
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Recruiting

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
Massachusetts General Hospital
American Cancer Society, Inc.; The Leukemia and Lymphoma Society

Active, not recruiting

Multimodal Sexual Dysfunction Intervention In HCT

Hematologic Diseases | Sexual Dysfunction | Hematopoietic Stem Cell Transplantation

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Mayo Clinic

Completed

Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Center for International Blood and Marrow Transplant...
Medical College of Wisconsin

Completed

Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database (09-SQOL)

Hematopoietic Stem Cell Transplantation

United States
M.D. Anderson Cancer Center
Janssen Scientific Affairs, LLC

Withdrawn

Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
Memorial Sloan Kettering Cancer Center
CivaTech Oncology

Active, not recruiting

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Abdominal Malignancy | Pelvic Malignancy

United States
University of Florida
National Institute of Nursing Research (NINR)

Completed

Developing Self-Management Interventions After HCT

Hematopoietic Stem Cell Transplant (HSCT)

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
Stanford University

Not yet recruiting

Aromatherapy Inhaler Use for HSCT Distress

Aromatherapy | Cancer Distress | Cancer Coping | Hematopoetic Stem Cell Transplant

United States
M.D. Anderson Cancer Center

Recruiting

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

Depression | Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Anxiety Disorder | Genetic Disorder

United States
Fred Hutchinson Cancer Center
National Marrow Donor Program; Vir Biotechnology, Inc.

Terminated

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 Infection

United States
Centre Hospitalier Universitaire, Amiens

Completed

Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families (JACintHE)

Hematopoietic/Lymphoid Cancer | Psychological Disorder

France
Vanderbilt University

Completed

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

United States
Centre Hospitalier Universitaire de la Réunion
Institut Paoli-Calmettes

Not yet recruiting

Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions (AlloRé)

Allogeneic Hematopoietic Stem Cell Transplantation

France
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant

Hematopoietic and Lymphoid Cell Neoplasm

United States
St. Jude Children's Research Hospital
Avadim Technologies, Inc.

Completed

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci

Hematopoietic Stem Cell Transplantation | Vancomycin-Resistant Enterococci

United States
Baylor College of Medicine

Withdrawn

Rituximab for GVHD (Rituximab GVHD)

Graft vs Host Disease | Alogenic Hematopoietic Transplant

United States
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Malignant Solid Neoplasm | COVID-19 Infection | Hematopoietic and Lymphatic System Neoplasm

United States
M.D. Anderson Cancer Center

Recruiting

The Impact of COVID-19 on Pulmonary Procedures

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 Infection

United States
University of California, San Francisco

Completed

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 Infection

United States
Cancer Research UK
Royal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham

Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. (DETERMINE)

Glioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological Malignancy

United Kingdom
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Withdrawn

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid Cancer

United States
University of Oklahoma
Oklahoma Center for the Advancement of Science and Technology

Terminated

Glucose Control In Hematopoetic Stem Cell Transplant

Hyperglycemia | Hematopoietic Stem Cell Transplantation

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
NYU Langone Health

Terminated

Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft

Hematopoietic Malignancies

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Malignancy

China
Shenzhen University General Hospital

Recruiting

Treatment of Malignant Tumors With NK Cell (NK cell)

Malignancy

China
BostonGene

Recruiting

BostonGene-Integrated Genomic Registry (BIGR)

Malignancy

United States
Sheba Medical Center
Tel Aviv University

Unknown

Tumor Monitoring Using Thermography During Radiation Therapy

Malignancy

Israel
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure (HaploRescue)

Hematologic Diseases | Allogeneic Hematopoietic Stem Cell Transplantation | Graft Failure
Vanderbilt University

Completed

Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 Infection

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 Infection

United States

Clinical Trials on Hematopoietic Malignancy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations